Figure 2.

Concept map portraying the medical context of use of EfientĀ® (prasugrel hydrochloride 10 mg, film coated tablets) for the prevention of atherothrombotic events. The specific elements of the new product are shown in blue.

Iordatii et al. BMC Medical Informatics and Decision Making 2013 13:10   doi:10.1186/1472-6947-13-10
Download authors' original image